Product Information
BUDESONIDE DR 3 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.4988 per EA under NDC 68382072001. Its NADAC has been published 427 times since Jun 20, 2018.
FDA first approved this application on May 4, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382072001
Classification
Generic
Dosage Form
CAPSULE, COATED PELLETS
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206134FDA Approved
5/4/2017
TE Code
AB
On Market Since
6/8/2017
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE DR 3 MG CAPSULE has been published 427 times since Jun 20, 2018, and over the history we have for it it has declined 85.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4988 per EA |
|---|---|
| All-time high | $3.5382 (Sep 12, 2018) |
| All-time low | $0.4242 (Nov 20, 2024) |
| 52-week high | $0.5230 |
| 52-week low | $0.4979 |
| Median price | $0.7799 |
| Average price | $1.0794 |
| Largest weekly change | -35.6% (Apr 22, 2020) |
| Weeks tracked | 427 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUDESONIDE DR 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE DR 3 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.4988 per EA (NDC 68382072001), effective Aug 19, 2026.
How has the price of BUDESONIDE DR 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUDESONIDE DR 3 MG CAPSULE has declined 85.6%. It has been tracked across 427 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for BUDESONIDE DR 3 MG CAPSULE?
Since Jun 20, 2018, the NADAC for BUDESONIDE DR 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $3.5382 (Sep 12, 2018), with a median of $0.7799 per EA.
Are there cheaper alternatives to BUDESONIDE DR 3 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUDESONIDE DR 3 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BUDESONIDE DR 3 MG CAPSULE?
BUDESONIDE DR 3 MG CAPSULE (NDC 68382072001) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.